Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir for Severe Fever with Thrombocytopenia Syndrome
ChiCTR2500104487Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in severe fever with thrombocytopenia syndrome (SFTS) comparing Experimental group (favipiravir) with Placebo group (2 arms). Primary endpoint: DBV nucleic acid at day 14. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
favipiravir
03
Conditions
severe fever with thrombocytopenia syndrome (SFTS)
Beyond the preview
Go deeper on ChiCTR2500104487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104487.